M&A Deal Summary |
|
---|---|
Date | 2020-07-30 |
Target | Lexicon Pharmaceuticals - XERMELO |
Sector | Life Science |
Buyer(s) | TerSera Therapeutics |
Sellers(s) | Lexicon Pharmaceuticals |
Deal Type | Divestiture |
Deal Value | 159M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2016 |
Sector | Life Science |
TerSera Therapeutics is a specialty pharmaceutical company focused on therapeutics to improve patient outcomes. The company was formed to acquire specialty pharmaceutical companies and products with a focus on select physician specialties. TerSera Therapeutics was founded in 2016 and is based in Lake Forest, Illinois.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Life Science) | 1 of 2 |
Type (Divestiture) | 1 of 2 |
State (Texas) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2020) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-10-22 |
MARGENZA
Rockville, Maryland, United States MARGENZA is an Fc-engineered, monoclonal antibody that targets the HER2 oncoprotein. HER2 is expressed by tumor cells in breast, gastroesophageal and other solid tumors. |
Buy | - |
Category | Company |
---|---|
Founded | 1995 |
Sector | Life Science |
Employees | 285 |
Revenue | 1M USD (2023) |
Lexicon Pharmaceuticals is a bio-pharmaceutical company focused on the development of breakthrough treatments for human disease. Lexicon Pharmaceuticals was founded in 1995 and is based in The Woodlands, Texas.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Texas) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2020) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-08-02 |
Symphony Icon
United States Symphony Icon Inc. is a drug development company. |
Buy | $90M |